The inspectors wrote that Lilly personnel found “unknown debris” in a production area and that raw drug ingredients produced there “were not adequately controlled pending satisfactory completion of evaluation by the quality unit.” According to the FDA website, its inspectors issue 483 forms when they have observed conditions that might violate federal regulations.